Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic Study. De Greef J, Yombi JC, Vincent A, Vandercam B, et al. J Infect Dis 2025 Feb 26:jiaf098. doi: 10.1093.

Read + Share

Amedeo Smart

Independent Medical Education

De Greef J, Yombi JC, Vincent A, Vandercam B, et al. Dolutegravir and Risk of Neuropsychiatric Adverse Events: a Pharmacogenetic Study. J Infect Dis 2025 Feb 26:jiaf098. doi: 10.1093.
PMID: 40036182